Lægen skal nøje afveje risikoen ved Refludan- administration mod de forventede fordele samtidig med at lægen tager højde for mulige metoder for at kontrollere blødning.
The physician should carefully weigh the risk of Refludan administration versus its anticipated benefit, taking into account possible measures to control bleeding.